Gregory MacMichael

Gregory MacMichael

Plus aucun poste en cours
70 ans
Health Technology
Consumer Services

Profil

Gregory MacMichael is the founder of CMC BioServices LLC, which was founded in 2010.
He held former positions as Vice President at Wyeth LLC, Global Head-Biologics Development at Novartis AG, Senior Vice President-Process Development at Rocket Pharmaceuticals, Inc., Senior Vice President-Development & Manufacturing at NantKwest, Inc. from 2017 to 2018, and Senior Vice President-Technical Operations at Sio Gene Therapies, Inc. from 2018 to 2019.
He was also the Chief Technology Officer at Castle Creek Biosciences, Inc. from 2020 to 2021 and Chief Technical Officer at Coya Therapeutics, Inc. He received a doctorate from Mississippi State University, a graduate and doctorate degree from North Carolina State University, and an undergraduate degree from The Pennsylvania State University.

Anciens postes connus de Gregory MacMichael

SociétésPosteFin
SIO GENE THERAPIES INC. Corporate Officer/Principal 01/07/2019
IMMUNITYBIO, INC. Corporate Officer/Principal 01/09/2018
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal 01/12/2016
COYA THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D -
Corporate Officer/Principal -
Voir l'expérience en détail de Gregory MacMichael

Formation de Gregory MacMichael

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

7

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

CMC BioServices LLC

  1. Bourse
  2. Insiders
  3. Gregory MacMichael
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇